Clinical Aspects and Management of Levodopa-Induced Dyskinesia

被引:19
|
作者
Tambasco, Nicola [1 ]
Simoni, Simone [1 ]
Marsili, Erica [1 ]
Sacchini, Elisa [1 ]
Murasecco, Donatella [1 ]
Cardaioli, Gabriela [1 ]
Rossi, Aroldo [1 ]
Calabresi, Paolo [1 ,2 ]
机构
[1] Univ Perugia, Azienda Osped, Neurol Clin, I-06156 Perugia, Italy
[2] Fdn S Lucia, IRCCS, I-00179 Rome, Italy
关键词
ADVANCED PARKINSONS-DISEASE; 24-HOUR PROLONGED RELEASE; DOPA-INDUCED DYSKINESIA; SUBTHALAMIC NUCLEUS STIMULATION; ADENOSINE A(2A) RECEPTORS; PLACEBO-CONTROLLED TRIAL; 10-YEAR FOLLOW-UP; DOUBLE-BLIND; MOTOR FLUCTUATIONS; ADJUNCTIVE THERAPY;
D O I
10.1155/2012/745947
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In Parkinson's disease, one of the most troublesome dilemmas is the treatment of levodopa-induced dyskinesia. After a few years, chronic treatment with levodopa is associated with the development of dyskinesias. Strategies to delay or to reduce dyskinesias are based on the change of levodopa dosing or the early use of dopamine agonists. Dopamine agonists with different pharmacological profile are available. Our paper was aimed to analyse the clinical impact and the management of dyskinesias with dopamine agonists.
引用
收藏
页数:12
相关论文
共 50 条